CIK 0001833214
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853899721
- Phone
- +1 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-22 | Link David Charles Director | Grant or award · Earnout Rights (Common Stock) | +4,887 | 4,887 | ||
| 2021-10-22 | Link David Charles Director | Grant or award · Employee Stock Option (right to buy) | +23,264 | 23,264 | ||
| 2021-10-22 | Link David Charles Director | Grant or award · Employee Stock Option (right to buy) | +69,793 | 69,793 | ||
| 2021-10-22 | Link David Charles Director | Grant or award · Earnout Rights (Restricted Stock Units) | +17,231 | 17,231 | ||
| 2021-10-22 | Bausch Christoph Lawrence Chief Science Officer | Grant or award · Employee Stock Option (right to buy) | +104,689 | 104,689 | ||
| 2021-10-22 | Bausch Christoph Lawrence Chief Science Officer | Grant or award · Employee Stock Option (right to buy) | +81,425 | 81,425 | ||
| 2021-10-22 | Bausch Christoph Lawrence Chief Science Officer | Grant or award · Employee Stock Option (right to buy) | +69,793 | 69,793 | ||
| 2021-10-22 | Bausch Christoph Lawrence Chief Science Officer | Grant or award · Employee Stock Option (right to buy) | +11,632 | 11,632 | ||
| 2021-10-22 | Bausch Christoph Lawrence Chief Science Officer | Grant or award · Earnout Rights (Restricted Stock Units) | +108,086 | 108,086 | ||
| 2021-10-22 | Ullerich Melissa Vera Chief Communications Officer | Grant or award · Employee Stock Option (right to buy) | +6,979 | 6,979 | ||
| 2021-10-22 | Ullerich Melissa Vera Chief Communications Officer | Grant or award · Employee Stock Option (right to buy) | +58,161 | 58,161 | ||
| 2021-10-22 | Ullerich Melissa Vera Chief Communications Officer | Grant or award · Employee Stock Option (right to buy) | +104,689 | 104,689 | ||
| 2021-10-22 | Ullerich Melissa Vera Chief Communications Officer | Grant or award · Earnout Rights (Restricted Stock Units) | +50,988 | 50,988 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award | +5,049,351 | 5,049,351 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award | +4,974,497 | 4,974,497 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Earnout Rights (Common Stock) | +2,039,938 | 2,039,938 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Employee Stock Option (right to buy) | +11,632 | 11,632 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Employee Stock Option (right to buy) | +34,896 | 34,896 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Employee Stock Option (right to buy) | +11,632 | 11,632 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Employee Stock Option (right to buy) | +11,632 | 11,632 |
Page 10 of 13 · 241 trades